Checkpoint Therapeutics Statistics
Total Valuation
CON has a market cap or net worth of $2.77 billion. The enterprise value is $4.88 billion.
| Market Cap | 2.77B |
| Enterprise Value | 4.88B |
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | Aug 21, 2025 |
Share Statistics
CON has 128.17 million shares outstanding. The number of shares has increased by 21.15% in one year.
| Current Share Class | 128.17M |
| Shares Outstanding | 128.17M |
| Shares Change (YoY) | +21.15% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.39% |
| Owned by Institutions (%) | 86.82% |
| Float | 115.36M |
Valuation Ratios
The trailing PE ratio is 18.40 and the forward PE ratio is 14.91. CON's PEG ratio is 1.81.
| PE Ratio | 18.40 |
| Forward PE | 14.91 |
| PS Ratio | 1.36 |
| Forward PS | 1.25 |
| PB Ratio | 8.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.83 |
| P/OCF Ratio | 10.67 |
| PEG Ratio | 1.81 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.51, with an EV/FCF ratio of 26.11.
| EV / Earnings | 32.95 |
| EV / Sales | 2.43 |
| EV / EBITDA | 12.51 |
| EV / EBIT | 15.07 |
| EV / FCF | 26.11 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 5.94.
| Current Ratio | 1.18 |
| Quick Ratio | 1.03 |
| Debt / Equity | 5.94 |
| Debt / EBITDA | 4.19 |
| Debt / FCF | 11.68 |
| Interest Coverage | 3.11 |
Financial Efficiency
Return on equity (ROE) is 18.98% and return on invested capital (ROIC) is 8.65%.
| Return on Equity (ROE) | 18.98% |
| Return on Assets (ROA) | 7.78% |
| Return on Invested Capital (ROIC) | 8.65% |
| Return on Capital Employed (ROCE) | 12.92% |
| Revenue Per Employee | $226,537 |
| Profits Per Employee | $16,726 |
| Employee Count | 8,856 |
| Asset Turnover | 0.77 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CON has paid $54.67 million in taxes.
| Income Tax | 54.67M |
| Effective Tax Rate | 26.03% |
Stock Price Statistics
The stock price has decreased by -2.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.08% |
| 50-Day Moving Average | 20.67 |
| 200-Day Moving Average | 21.20 |
| Relative Strength Index (RSI) | 65.54 |
| Average Volume (20 Days) | 778,007 |
Short Selling Information
The latest short interest is 2.55 million, so 1.99% of the outstanding shares have been sold short.
| Short Interest | 2.55M |
| Short Previous Month | 1.69M |
| Short % of Shares Out | 1.99% |
| Short % of Float | 2.21% |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, CON had revenue of $2.01 billion and earned $148.13 million in profits. Earnings per share was $1.17.
| Revenue | 2.01B |
| Gross Profit | 563.83M |
| Operating Income | 323.80M |
| Pretax Income | n/a |
| Net Income | 148.13M |
| EBITDA | 390.24M |
| EBIT | 323.80M |
| Earnings Per Share (EPS) | $1.17 |
Balance Sheet
The company has $73.88 million in cash and $2.18 billion in debt, giving a net cash position of -$2.11 billion or -$16.46 per share.
| Cash & Cash Equivalents | 73.88M |
| Total Debt | 2.18B |
| Net Cash | -2.11B |
| Net Cash Per Share | -$16.46 |
| Equity (Book Value) | 367.38M |
| Book Value Per Share | 2.67 |
| Working Capital | 60.10M |
Cash Flow
In the last 12 months, operating cash flow was $259.70 million and capital expenditures -$72.79 million, giving a free cash flow of $186.91 million.
| Operating Cash Flow | 259.70M |
| Capital Expenditures | -72.79M |
| Free Cash Flow | 186.91M |
| FCF Per Share | $1.46 |
Margins
Gross margin is 28.10%, with operating and profit margins of 16.14% and 7.44%.
| Gross Margin | 28.10% |
| Operating Margin | 16.14% |
| Pretax Margin | 10.47% |
| Profit Margin | 7.44% |
| EBITDA Margin | 19.45% |
| EBIT Margin | 16.14% |
| FCF Margin | 9.32% |
Dividends & Yields
This stock pays an annual dividend of $0.25, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | $0.25 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 15.96% |
| Buyback Yield | -21.15% |
| Shareholder Yield | -19.99% |
| Earnings Yield | 5.35% |
| FCF Yield | 6.75% |
Analyst Forecast
The average price target for CON is $29.00, which is 34.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $29.00 |
| Price Target Difference | 34.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CON has an Altman Z-Score of 1.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.82 |
| Piotroski F-Score | 5 |